| [1] |
Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease[J]. Mod Pathol, 2012, 25(9): 1181-1192.
|
| [2] |
张盼盼, 赵继志, 王木, 等. IgG 4相关性疾病346例临床特征分析[J]. 中华内科杂志, 2017, 56(9): 644-649.
|
| [3] |
Stone JH, Zen Y, Deshpande V. IgG4-related disease[J]. New Engl J Med, 2012, 366: 539-551.
|
| [4] |
Löhr JM, Vujasinovic M, Rosendahl J, et al. IgG4-related diseases of the digestive tract[J]. Nat Rev Gastroenterol Hepatol, 2022, 19(3): 185-197.
|
| [5] |
Umehara H, Okazaki K, Kawa S, et al. The 2020 revised comprehensive diagnostic(RCD) criteria for IgG4-RD[J]. Mod Rheumatol, 2021, 31(3): 529-533.
|
| [6] |
Zhang L, Smyrk TC. Autoimmune pancreatitis and IgG4-related systemic diseases[J]. Int J Clin Exp Pathol, 2010, 3(5): 491-504.
|
| [7] |
Wallace ZS, Zhang Y, Perugino CA, et al. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts[J]. Ann Rheumat Dis, 2019, 78(3): 406-412.
|
| [8] |
Bohlok A, El Khoury M, Tulelli B, et al. A rare presentation of IgG4 related disease as a gastric antral lesion: Case report and review of the literature[J]. Int J Surg Case Rep, 2018, 51: 244-247.
|
| [9] |
Sawada H, Czech T, Silangcruz K, et al. Clinicopathological characteristics of gastric IgG4-related disease: systematic scoping review[J]. J Gastroenterol Hepatol, 2022, 37(10): 1865-1872.
|
| [10] |
Skorus U, Kenig J, Mastalerz K. IgG4-related disease manifesting as an isolated gastric lesion-a literature review[J]. Pol J Surg, 2018, 90(4): 41-45.
|
| [11] |
Seo HS, Jung YJ, Park CH, et al. IgG4-related disease in the stomach which was confused with gastrointestinal stromal tumor(GIST): two case reports and review of the literature[J]. J Gastric Cancer, 2018, 18(1): 99.
|
| [12] |
Khan S, Zhu LP, Jiang K, et al. Immunoglobulin G4-Related Disease Manifesting as Isolated, Typical, and Nontypical Gastroesophageal Lesion: A Research of Literature Review[J]. Digestion, 2020, 101(5): 506-21.
|
| [13] |
Della-Torre E, Lanzillotta M, Doglioni C. Immunology of IgG4-related disease[J]. Clin Exp Immunol, 2015, 181(2): 191-206.
|
| [14] |
Perugino CA, AlSalem SB, Mattoo H, et al. Identification of galectin-3 as an autoantigen in patients with IgG4-related disease[J]. J Allergy Clin Immunol, 2019, 143(2): 736-745. e6.
|
| [15] |
Maehara T, Mattoo H, Mahajan VS, et al. The expansion in lymphoid organs of IL-4+ BATF+ T follicular helper cells is linked to IgG4 class switching in vivo[J]. Life Sci Alliance, 2018, 1(1): e201800050.
|
| [16] |
Terao C, Ota M, Iwasaki T, et al. IgG4-related disease in the Japanese population: a genome-wide association study[J]. Lancet Rheumatol, 2019, 1(1): e14-e22.
|
| [17] |
Ishikawa Y, Terao C. Genetic analysis of IgG4-related disease[J]. Mod Rheumatol, 2020, 30(1): 17-23.
|
| [18] |
Guarneri F, Guarneri C, Benvenga S. Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry?[J]. J Cell Mol Med, 2005, 9(3): 741-744.
|
| [19] |
Aparisi L, Farre A, Gomez-Cambronero L, et al. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis[J]. Gut, 2005, 54(5): 703-709.
|
| [20] |
Frulloni L, Lunardi C, Simone R, et al. Identification of a novel antibody associated with autoimmune pancreatitis[J]. New Engl J Med, 2009, 361(22): 2135-2142.
|
| [21] |
Culver EL, Smit WL, Evans C, et al. No evidence to support a role for Helicobacter pylori infection and plasminogen binding protein in autoimmune pancreatitis and IgG4-related disease in a UK cohort[J]. Pancreatology, 2017, 17(3): 395-402.
|
| [22] |
Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease[J]. Arthritis Rheumatol, 2015, 67(7): 1688-1699.
|
| [23] |
Carruthers MN, Topazian MD, Khosroshahi A, et al. Rituximab for IgG4-related disease: a prospective, open-label trial[J]. Ann Rheumat Dis, 2015, 74(6): 1171-1177.
|
| [24] |
Ebbo M, Grados A, Samson M, et al. Long-term efficacy and safety of rituximab in IgG4-related disease: data from a French nationwide study of thirty-three patients[J]. PloS One, 2017, 12(9): e0183844.
|
| [25] |
Omar D, Chen Y, Cong Y, et al. Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis[J]. Rheumatology, 2020, 59(4): 718-726.
|
| [26] |
Yoshifuji H, Umehara H. Glucocorticoids in the treatment of IgG4-related disease-Prospects for new international treatment guidelines[J]. Mod Rheumatol, 2023, 33(2): 252-257.
|